Vaccinogen
Frederick
About Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases. It operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery. The company was incorporated in 2007 and is based in Frederick, Maryland.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $99.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2014)
- Ticker: otcqb:VGEN
- Website: vaccinogeninc.com
- Phone: 301-668-8400
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vaccinogen-1851725 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.